MedPath

Effects of asthma medicine on physical performance in patients with COPD and changes in immune response after exercise

Conditions
To investigate the effects of terbutaline on repeated exercise performance in patients with chronic obstructive pulmonary disease (COPD). Furthermore to examine the inflammatory response during and after exercise in patients with COPD.
Therapeutic area: Body processes [G] - Physiological processes [G07]
Registration Number
EUCTR2011-002987-26-DK
Lead Sponsor
Bispebjerg Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
Male
Target Recruitment
10
Inclusion Criteria

-Sex: Male
-Age: 45-75
-COPD classified as GOLD2, with a FEV1 between 30 and 50%
-In a physical condition that allows cycling
-smoker or former smoker
-Informed consent
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 10
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

-Cardiovascular diseases
-Other respiratory diseases than COPD, as well as, lung cancer
-Allergy towards the study medicine
-Use of beta2-agonist 48 hours prior to study days
-COPD rehabilitation 3 months prior to study
-Patients treated with beta-blockers

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath